TOKYO, Dec 11, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that it has received approval for “URECE®” (brand name in China: “优乐思®”, generic name: dotinurad) from the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia. This approval is based on the results of a […]
